BIOCRYST PHARMACEUTICALS INC Balance Sheet
BCRX / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
BIOCRYST PHARMACEUTICALS INC had $514M in total assets with negative shareholders' equity of $119M as of FY2025. Total debt was $0 against $90M in cash, resulting in a $90M net cash position.
Based on SEC 10-K filings.
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89.7M | $104.7M | $110.6M | $304.8M | $504.4M | $272.1M | $114.2M | $26.7M | $50.3M | $22.1M | $28.9M | $54.5M | $21.2M | $13.6M | $41.1M |
| Accounts Receivable | $106.8M | $79.1M | $57.0M | $50.6M | $29.4M | $8.6M | $22.1M | $4.3M | $6.1M | $8.8M | $6.2M | - | - | - | - |
| Inventory | $5.4M | $8.1M | $28.7M | $27.5M | $15.8M | $7.0M | $0 | $1.6M | - | $500.0K | $1.6M | $683.0K | - | - | $263.0K |
| Current Assets | $404.3M | $422.0M | $496.0M | $516.5M | $566.1M | $323.8M | $164.3M | $114.4M | $125.4M | $67.0M | $63.8M | $89.3M | $42.1M | $42.0M | $52.9M |
| PP&E (Net) | $8.8M | $7.8M | $7.9M | $8.6M | $8.7M | $7.1M | $7.3M | $9.1M | $9.5M | $9.9M | $5.1M | $207.0K | $306.0K | $583.0K | $1.1M |
| Total Assets | $514.2M | $490.4M | $517.0M | $550.0M | $588.2M | $334.7M | $175.3M | $146.8M | $178.3M | $89.8M | $122.4M | $136.9M | $48.9M | $57.4M | $82.2M |
| Current Liabilities | $196.1M | $160.4M | $150.0M | $105.5M | $103.7M | $105.7M | $92.3M | $69.5M | $74.8M | $54.4M | $62.3M | $57.7M | $15.3M | $17.2M | $26.3M |
| Total Debt | $0 | $314.9M | $303.2M | $231.6M | $298.1M | $122.6M | $0 | $30.0M | $23.0M | $23.0M | - | - | - | - | - |
| Shareholders' Equity | -$119.2M | -$475.9M | -$455.5M | -$294.6M | -$107.0M | -$19.3M | $38.3M | $49.2M | $83.8M | $1.6M | $47.7M | $75.6M | -$1.1M | $65.5M | $86.3M |